BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25354025)

  • 1. Short communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers.
    Batraville LA; Richard J; Veillette M; Labbé AC; Alary M; Guédou F; Kaufmann DE; Poudrier J; Finzi A; Roger M
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1145-9. PubMed ID: 25354025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women.
    Mkhize NN; Durgiah R; Ashley V; Archary D; Garrett NJ; Karim QA; Karim SS; Moore PL; Yates N; Passmore JA; Tomaras GD; Morris L
    AIDS; 2016 Apr; 30(7):1005-14. PubMed ID: 26836790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein.
    Carrillo J; Restrepo C; Rallón NI; Massanella M; del Romero J; Rodríguez C; Soriano V; Clotet B; Benito JM; Blanco J
    AIDS; 2013 Jun; 27(9):1375-85. PubMed ID: 23945502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.
    Madhavi V; Wines BD; Amin J; Emery S; ; Lopez E; Kelleher A; ; Center RJ; Hogarth PM; Chung AW; Kent SJ; Stratov I
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28701393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Correlates of Disease Progression in Linked HIV-1 Infection.
    Tuen M; Bimela JS; Banin AN; Ding S; Harkins GW; Weiss S; Itri V; Durham AR; Porcella SF; Soni S; Mayr L; Meli J; Torimiro JN; Tongo M; Wang X; Kong XP; Nádas A; Kaufmann DE; Brumme ZL; Nanfack AJ; Quinn TC; Zolla-Pazner S; Redd AD; Finzi A; Gorny MK; Nyambi PN; Duerr R
    Front Immunol; 2019; 10():1062. PubMed ID: 31139189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals.
    Prévost J; Richard J; Ding S; Pacheco B; Charlebois R; Hahn BH; Kaufmann DE; Finzi A
    Virology; 2018 Feb; 515():38-45. PubMed ID: 29248757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.
    Fouda GG; Yates NL; Pollara J; Shen X; Overman GR; Mahlokozera T; Wilks AB; Kang HH; Salazar-Gonzalez JF; Salazar MG; Kalilani L; Meshnick SR; Hahn BH; Shaw GM; Lovingood RV; Denny TN; Haynes B; Letvin NL; Ferrari G; Montefiori DC; Tomaras GD; Permar SR;
    J Virol; 2011 Sep; 85(18):9555-67. PubMed ID: 21734046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells.
    Dhande J; Angadi M; Murugavel KG; Poongulali S; Nandagopal P; Vignesh R; Ghate M; Kulkarni S; Thakar M
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):277-282. PubMed ID: 30211779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
    Sun Z; Li J; Hu X; Shao Y; Zhang MY
    Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly-Exposed HIV-1 seronegative Female Commercial Sex Workers sustain in their genital mucosa increased frequencies of tolerogenic myeloid and regulatory T-cells.
    Thibodeau V; Fourcade L; Labbé AC; Alary M; Guédou F; Poudrier J; Roger M
    Sci Rep; 2017 Mar; 7():43857. PubMed ID: 28262752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells.
    Anand SP; Prévost J; Baril S; Richard J; Medjahed H; Chapleau JP; Tolbert WD; Kirk S; Smith AB; Wines BD; Kent SJ; Hogarth PM; Parsons MS; Pazgier M; Finzi A
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities.
    Seaton KE; Ballweber L; Lan A; Donathan M; Hughes S; Vojtech L; Moody MA; Liao HX; Haynes BF; Galloway CG; Richardson BA; Karim SA; Dezzutti CS; McElrath MJ; Tomaras GD; Hladik F
    PLoS One; 2014; 9(7):e101863. PubMed ID: 25054205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 mimetics sensitize HIV-1-infected cells to ADCC.
    Richard J; Veillette M; Brassard N; Iyer SS; Roger M; Martin L; Pazgier M; Schön A; Freire E; Routy JP; Smith AB; Park J; Jones DM; Courter JR; Melillo BN; Kaufmann DE; Hahn BH; Permar SR; Haynes BF; Madani N; Sodroski JG; Finzi A
    Proc Natl Acad Sci U S A; 2015 May; 112(20):E2687-94. PubMed ID: 25941367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
    Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
    J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
    Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.
    Bélec L; Tévi-Bénissan C; Lu XS; Prazuck T; Pillot J
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):719-29. PubMed ID: 7576932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Immunity to HIV: A Template for Vaccine Strategies.
    Fourcade L; Poudrier J; Roger M
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29690575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.